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1.  Introduction
Bone homeostasis requires balanced interactions 
between osteoblasts and osteoclasts. Osteoporosis, 
therefore, involves a reduction in skeletal mass due 
to an imbalance between bone resorption and bone 
formation [1]. Over the past 10 years, patients with 
osteoporosis have been treated with antiresorptive 
agents (estrogens, bisphosphonates, calcitonin), 
which reduce osteoclast bone resorption. These 
agents prevent bone from being broken down; al-
lowing remodeling spaces to be filled, and improve 
bone strength and reduce fracture risk [2]. Recently, 
attention has turned away from osteoclast inhibi-
tion and towards agents including parathyroid hor-
mone, growth hormone, insulin-like growth factor-1, 
bone morphogenetic protein-2, and vascular endo-
thelial growth factor, which stimulate osteoblasts 
to form new bone and anabolic agents [3]. There-
fore, anabolic agents with the ability to stimulate 
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new bone formation and correct imbalances of tra-
becular microarchitecture, which are characteris-
tic of established osteoporosis, are desirable [4]. 
Among these, in vitro studies, especially studies re-
lated to components isolated from Chinese herbal 
medicine, are gaining attention [5].
Osthole is one of the main components of the 
dried seeds from the Fructus Cnidii (FC) plant, which 
is also known by its traditional name She-Chuang-Zi 
(SCZ) [6]. FC is known for its effects including kid-
ney warming, which is thought to invigorate Yang, 
and the clearance of heat and toxic materials from 
the body. FC is used in Traditional Chinese Medicine 
(TCM) in tonics and aphrodisiacs to treat impotence 
and lumbar pain in clinical practice [7,8]. Weak 
bones and bone loss are generally regarded to be 
caused by kidney deficiencies in TCM, but the bone-
forming actions of FC on osteoporosis have rarely 
been reported. Osthole was reported to exhibit 
estrogen-like effects, preventing postmenopausal 
osteoporosis in ovariectomized rats [9], however, 
the biological effects of osthole on bone cells are 
relatively unknown. In this study, we determined the 
bone-inducing effects of osthole, the main compo-
nent of FC, on osteoblast cells in vitro. We also 
describe the promoting activities of different con-
centrations of osthole on osteoblast cells.
2.  Materials and Methods
2.1.  Reagents and materials
The Chinese herb FC was obtained and its compo-
nent osthole (7-methoxy-8-isopentenoxycoumarin, 
molecular weight: 244.29) was prepared by the 
National Institute for the Control of Pharmaceutical 
and Biological Products (product number: 110822-
200406). Nine pre-experimentally-determined con-
centrations of osthole (0, 2.5, 5, 10, 20, 40, 80, 
160, 320, and 640 μg/mL) were diluted with DMEM-
F12 (Invitrogen, Carlsbad, CA, USA) containing 15% 
fetal bovine serum (FBS; Hyclone, Thermo Scientific, 
Waltham, MA, USA) and 1% penicillin-streptomycin. 
All solutions used in cell cultures were sterilized 
by filtration through 0.2 μm Millipore filters and 
stored in a refrigerator at 4ºC until use. D-Hanks’ 
solution, penicillin G, streptomycin, and all other 
chemicals were purchased from Wako Pure Chemi-
cals (Osaka, Japan), unless stated otherwise.
2.2.  Cell culture
Primary osteoblastic cells were prepared from neo-
natal (0−3 days old) Sprague-Dawley rats (CLEA 
Japan, Osaka, Japan). The rats were housed in a 
constant temperature-controlled environment (23ºC) 
with 60% relative humidity under a 12-hour light/
dark cycle. The procedures involving the animals 
and their care were in full compliance with our in-
stitutional regulations and the current interna-
tional laws and policies [10]. The rats were killed 
by being immersed in 70% alcohol for 10 minutes, 
and then the rat calvaria were excised, stripped of 
soft tissue, washed three times in D-Hanks’ solu-
tion containing 0.25% trypsin, and cut into small 
pieces with a dissector at a volume of about 1 mm3. 
The bone tissue pieces were homogeneously seeded 
at 1 cm intervals in flasks, which had been incu-
bated in advance for 10 minutes with 1 mL of DMEM 
medium. After being kept inversely in an incubator 
at 37ºC in a 5% CO2 fully humidified atmosphere 
for 2 hours, the flasks were then reversed to their 
normal position and 5 mL of DMEM/F12 containing 
15% FBS and 1% penicillin-streptomycin was added 
in order to avoid adhered tissue pieces floating 
to the surface from the bottom. Flasks were then 
incubated continuously for 3 days in an incubator. 
Media was replaced every 3 days. After reaching 
confluence, the cells were passaged every 7 days.
2.3.  Identification of osteoblast cells
Cellular morphology and growth were observed 
daily, after the first 3 days in primary culture, using 
an inverted microscope, whereupon images were 
obtained. We used methods similar to those de-
scribed elsewhere for the identification of osteo-
blasts, in addition to hematoxylin-eosin staining [11]. 
Alkaline phosphatase (ALP) staining was also per-
formed using the Gomori Calcium-Cobalt (Ca-Co) 
method. In brief, when the cells had reached con-
fluence, after fixation with a solution of 95% alco-
hol for 10 minutes, the cells were incubated in an 
incubator at 37ºC for 4−6 hours. The cells were 
then stained with solutions of 2% cobalt nitrate 
and 1% ammonium sulfide in turn. After being air-
dried, the slides were finally mounted and used 
for microscopy [12]. Immunocytochemistry, as de-
scribed by others, was also performed to identify 
osteoblasts [13]. Briefly, cells were planted onto a 
coverslip. When 70% confluence had been reached, 
the coverslips were fixed using a 95% alcohol solu-
tion for 5 minutes. Mouse anti-collagen (type clone 
Col-1: 2456) was used as a primary antibody at a 
ratio 1:100, which was diluted in 0.3% Triton X-100 
and 5% normal goat serum in phosphate buffered 
saline (PBS). The cells were incubated with the 
primary antibody present at 4ºC overnight before 
being washed in PBS. Anti-mouse IgG TRITC anti-
body produced in goats (Sigma-Aldrich, St-Louis, 
MO, USA) was used as the secondary reagent 
(1:100) after being diluted in 0.3% Triton X-100/
PBS and incubated for 2 hours at 4ºC. After a final 
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brief wash, the coverslips were mounted in glycerol 
and viewed with a fluorescent microscope.
2.4.  Colorimetric assay for cell viability
An [3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetra-
zolium bromide] (MTT) assay was performed to es-
timate cell proliferation, according to the method 
described by Singh et al [5]. The concentrations of 
osthole used were determined according to the 
changes in growth curves, which reflected the cor-
relation between the various concentrations and 
cell numbers in our pre-examination (data not 
shown). Negative controls were treated with the 
same supplemented medium but without the pres-
ence of drugs. When about 80% confluence had been 
reached, the cell layer was digested by trypsin and 
cultured in a 96-well culture plate (5 × 103 cells/
well) for 24 hours. The culture medium was re-
placed with solutions of varying concentrations of 
osthole (0, 2.5, 5, 10, 20, 40, 80, 160, 320, and 
640 μg/mL) and incubated for 24 hours. MTT was 
dissolved in PBS at a concentration of 5.0 mg/mL. 
MTT solution (50 μL) was added to each well of a 
culture plate containing 200 μL medium and incu-
bated at 37ºC for 4 hours. The supernatant was 
then carefully removed without disturbing the dark 
blue formazan crystals. DMSO (50 μL) was then 
added to each well and mixed thoroughly to dis-
solve the formazan crystals. The plates were then 
read using a multiskan plate reader (Multiskan JX; 
Labsystems, Tokyo, Japan) with a wavelength of 
540 nm. Readings are presented as optical density 
values.
2.5.  Analysis of ALP
After 7 days of culture, the differentiation of osteo-
blasts was determined by measuring their ALP ac-
tivity. The medium was removed from the wells, 
and the cell layer was washed twice with PBS. 0.1% 
Triton X-100 (Sigma-Aldrich; 100 μL/well) was used 
to lyse the cells for 5 minutes at room tempera-
ture. The chromogenic substrate used to measure 
ALP was 10 mM 4-nitrophenyl phosphate (Amresco, 
Solon, OH, USA). The ALP concentration was de-
termined by kinetic measurement of the absor-
bance at 405 nm using standards with defined ALP 
concentrations [14].
2.6.  Bone nodules
Von Kossa’s stain was utilized to assess the forma-
tion of the mineralized matrix. A total of 2 × 104 os-
teoblast cells/wells were added to culture medium 
containing 1% FBS, 1% penicillin-streptomycin, 50 μg/
mL ascorbic acid, and 10 mM β-glycerophosphate; 
the cells were incubated for 21 days in a 24-well 
plate. Culture medium was mixed with one of the 
nine concentrations of osthole used in the MTT and 
ALP assays at a volume ratio of 9:1. The medium 
was replaced every 2 days. After 21 days, the cul-
tured cells were fixed with a 100% methanol solu-
tion and stained with the Alizarin Red Method [15]. 
Mineralization was quantified by visual counting at 
high magnification of five random fields with an 
optical microscope. Orange-red nodules with sharp 
borders and a diameter larger than 200 μm were 
counted, and the mean value was taken as the final 
result [16].
2.7.  Statistical analysis
Data are expressed as mean ± SEM. Statistical dif-
ferences among groups were evaluated by one-way 
analysis of variance using SPSS version 11.0 (SPSS 
Inc., Chicago, IL, USA). The statistical differences 
between the treatment and control were deter-
mined by the Fisher’s least significant difference 
test. The levels of statistical significance were set 
to p < 0.05, and the results that met this condition 
are indicated in the figures with an asterisk.
3.  Results
3.1.  Observation of cell morphology
The numbers of cultured cells gradually began to 
increase after 3 days of incubation of the tissue 
pieces. Cells were seen to adhere to the bottom of 
the culture dish and possessed typical shapes such 
as triangular, fusiform, and polygonal, with one 
or two elliptical nuclei in the center of the cells 
(Figure 1A). Following this observation, the cell 
numbers increased gradually and reached conflu-
ence at 10 days of incubation. Figure 1B shows os-
teoblast cells of the second passage at 5 days, 
from which projections had formed, with the cells 
appearing to grow in a radial fashion. Hematoxylin-
eosin staining images showed high purity of cells 
and the same characteristics as described above. 
Nuclei were stained an amethyst color, and the cy-
toplasm was stained pink (Figure 1C). To confirm 
that the cultured cells were osteoblasts, in addition 
to the hematoxylin-eosin staining described above, 
Ca-Co and immunofluorescence staining were applied 
to identify the osteoblastic cells. Cellular cytoplasm 
was stained grayish-black due to ALP staining and 
a brown-stained positive reaction was observed to-
gether with yellow shiny nodules marked by tetra-
cycline. These findings are consistent with other 
studies [10,13] characterizing osteoblast histology 
(Figure 1D).
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3.2.  Effects of osthole concentration on 
osteoblast activity
The effects of various concentrations of osthole on 
the proliferation of osteoblast cells was measured 
by an MTT assay according to the method described 
above (Figure 2). Osthole concentrations lower than 
10 μg/mL did not affect the proliferation of osteo-
blasts. However, osthole was effective at con-
centrations higher than 20 μg/mL, and significant 
enhancement was seen at concentrations from 40 
to 320 μg/mL compared with the blank control (p < 
0.05). The most effective concentration was 160 μg/ 
mL. However, the proliferative activity of osthole 
dropped at concentrations higher than 320 μg/mL.
Figure 3 shows the effects of various concentra-
tions of osthole on the ALP activity of osteoblasts. 
Osthole concentrations lower than 40 μg/mL pro-
duced less ALP upregulation. Additionally, increases 
in concentration dependent cell differentiation be-
came more evident and were significantly enhanced 
at concentrations ranging from 40 μg/mL to 320 μg/
mL compared with the blank control group (p < 0.05). 
The most effective action was seen at 80 μg/mL. 
As for MTT, concentrations of osthole higher than 
320 μg/mL inhibited the total metabolic activity of 
osteoblasts.
3.3.  Observation of bone nodules
Figure 4 shows the number of total calcified nod-
ules formed in osteoblast cultures at various os-
thole concentrations. As a matter of principle, the 
nodule number should correlate with the effects 
of MTT and ALP, which reflect the proliferation and 
the activities of bone cells. However, in the pres-
ence of various concentrations of osthole treatment, 
significant changes in the number of nodules were 
only seen at 40 and 80 μg/mL.
4.  Discussion
The enzymatic digestion method is most commonly 
used to culture osteoblast cells in vitro and is con-
sidered to have the important advantage of easily 
obtaining large quantities of cells. This method also 
has disadvantages, such as a lower degree of cell 
Figure 1   (A) Primary cultured osteoblast cells at 3 days (4×). (B) Osteoblast cells of the second passage at 5 days 
(40×). (C) Hematoxylin-eosin staining (100×). (D) Immunofluorescence staining (200×).
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purity due to the complicated manipulation pro-
cess and the possibility of affecting the viability and 
adherence of cells due to the enzymatic process 
involved. Using bone tissue pieces also has its dif-
ficulties, such as obtaining a sufficient quantity of 
cells and a lower speed of cell liberation [17]. In 
this study, we modified the traditional tissue piece 
method by incubating the flask for 1 hour in ad-
vance with DMEM/F12 medium at 37ºC in an incu-
bator. This produces better viability and a larger 
quantity of osteoblasts than the methods that lacked 
pre-incubation that we tested in our pilot study 
(data not shown). Moreover, cell identification by 
hematoxylin-eosin, ALP specific staining, and im-
munofluorescence staining also confirmed a higher 
purity of osteoblasts; therefore, we suggest that 
pre-incubating is a very important process for the 
tissue piece method.
Several Chinese herbs and herb extracts have 
proven effective at improving bone properties and 
enhancing mineralization in vitro and have thus 
been shown to be potential bone-inducing agents 
[15,18]. Since there is a close relationship between 
kidney and bone production, a majority of these 
studies have focused on medicines with kidney-
tonifying activities, such as Fructus Ligustri Lucidi 
(Nv-Zhen-Zi), Hominis Placenta (Zi-Hec-Che), Herba 
Epimedii (Yin-Yang-Huo) and Rhizoma Drynariae 
(Gu-Sui-Bu). FC is a medicine that is used in TCM 
to warm the kidney as a way of invigorating Yang, 
expel cold and wind, eliminate dampness and de-
stroy parasites. Thus, FC is used to treat impotence, 
sterility due to uterine coldness, leucorrhea due 
to cold dampness, lumbago due to damp arthral-
gia, pudendal damp itching, and eczema. Kuo et al 
[19] reported osthole-mediated cell differentia-
tion through the bone morphogenetic protein-2/
p38 and extracellular signal-regulated kinase 1/2 
pathway in human osteoblast cells; whereas, no 
significant increase in the proliferation of MG-63 
or hFob cells was exhibited.
We observed the bone-inducing activities of 
osthole using MTT and ALP assays to examine the 
proliferation and differentiation of osteoblasts. The 
addition of osthole at concentrations lower than 
40 μg/mL did not affect the proliferation or differ-
entiation of osteoblasts. ALP is a protein involved 
in bone metabolism and one of the marker enzymes 
of mature osteoblastic cells, which plays an impor-
tant role during calcification in vitro. Its level com-
monly increases in the early period of osteoblastic 
differentiation and decreases in the mineralized pe-
riod [13]. In our study, concentrations ranging from 
40−320 μg/mL caused corresponding increases in 
total metabolic activity and ALP activity in a dose-
dependent manner, which indicates that osthole 
induces osteoblastic bone formation through the 
upregulation of ALP activity, however, a concentra-
tion of 640 μg/mL did inhibit the growth of osteo-
blast cells and produced cytotoxic activity.
By contrast, the positive staining of mineralized 
bone nodules by Von Kossa’s stain, which was at-
tributed to increased cell viability, not only re-
flects increased bone deposition but also that the 
osteoblasts had matured. Concentrations from 40−
160 μg/mL tended to increase the formation of bone 
nodules compared with the blank control group, 
but significant increases were only detected at 40 
and 80 μg/mL. Previous studies reported different 
Figure 2   Effects of osthole at various concentrations 
on the proliferation of osteoblast cells in vitro, as deter-
mined by 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetra-
zolium bromide or MTT assay (*p < 0.05 vs. control).
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Figure 3   Effects of osthole at various concentrations 
on the differentiation of osteoblasts in vitro, as deter-
mined by an alkaline phosphatase (ALP) activity assay 
(*p < 0.05 vs. control).
Figure 4   Effects of osthole at various concentrations 
on the formation of mineralized nodules in an osteoblast 
culture system (*p < 0.05 vs. control).
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observation periods such as 14 days, or longer than 
25 days [12,17]. We suppose that the reduced ef-
fects on the mineralization of nodules seen at con-
centrations from 160−320 μg/mL may be attributed 
to our longer follow-up period of 21 days, which led 
to the possibility of a higher density of osteoblasts 
forming due to their active proliferation. Also, the 
presented congregation and overlapping limited 
the further growth of osteoblast cells. Additionally, 
the inconsistency between the results for the bone 
nodules and the ALP data also confirmed that osteo-
blastic differentiation decreased in the mineralized 
period.
Based on the above findings, this study demon-
strates that osthole not only considerably stimulated 
osteoblastic proliferation and differentiation, but 
also enhanced the deposition of calcium and phos-
phate at concentrations ranging from 40−160 μg/mL. 
Other studies have reported that osthole has an 
estrogen-like effect and prevents postmenopausal 
osteoporosis in ovariectomized rats [9]. To investi-
gate whether the bone-inducing actions seen in 
this in vitro study can also be attributed to the 
same effect, an additional experiment involving 
co-incubation with an estrogen receptor antago-
nist should be performed to determine whether 
the effects of osthole on cell proliferation, differen-
tiation, and mineralization are estrogen receptor 
dependent.
In conclusion, this study demonstrated that os-
thole accelerates osteoblastic proliferation and dif-
ferentiation at concentrations from 40−160 μg/mL 
and that concentrations near to 80 μg/mL seem to 
be the most effective experimental concentration 
for inducing bone nodule formation. These findings 
support the idea that osthole is effective at inducing 
osteoblastic bone formation through the upregulation 
of ALP activity, and since findings from cell culture 
and animal experiments concur, the development 
of a pharmaceutical therapy for osteoporosis may 
be possible in the future.
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